ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome

Inclusion Criteria: * Presence of metabolic and/or alcoholic steatotic liver disease, as defined by the new nomenclature (MASLD, ALD, or mixed MetALD) * Liver biopsy performed (less than 2 months ago) or planned as part of treatment for diagnosis of cirrhosis ("Control" group without HCC) or diagnosis of HCC on cirrhosis ("Case" group) * Patient affiliated to or benefiting from a social security scheme * Patient having signed an informed consent to participate in the study (bio-collection) Exclusion Criteria: * Causes of chronic liver disease other than MASLD, ALD, or MetALD * Decompensation of cirrhosis in the two years prior to inclusion (ascites, hepatic encephalopathy, gastrointestinal variceal hemorrhage, liver failure, hepatorenal syndrome) * For the "Control" group: history of hepatocellular carcinoma * Pregnant, breast-feeding or parturient women * Persons deprived of liberty by judicial or administrative decision